HIGHLIGHTS
- who: HER and colleagues from the National Institute, Research Unit have published the Article: u0423u0414u041a: 615.618.19:576.52 HER2/neu, in the Journal: (JOURNAL)
- what: The important result of this study is the confirmation that breast cancer with low HER2 expression level (IHC+ or IHC2+/FISHnegative) is more often observed in hormone-positive breast cancer (luminal type A or luminal type B) than in triple-negative one (65,4% versus 36,6%).
- future: To determine the patients who may potentially benefit from the new target drugs among the patients with HER2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.